Innovative regenerative medicines in the EU: a better future in evidence?

BMC Med · 2017 · PMC5341436 · PMID 28270209

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Even where there may be significant potential benefits over current therapies, these may not be known with a high level of certainty at the time of licensing [ 8 , 9 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.